Multinational drugmakers have been charged by the Indian State TradingCorp of creating a panic in Sri Lanka over the quality of Indian vaccines. The STC is questioning claims in the Sri Lanka media that it had supplied sub-standard diphtheria, whooping cough and tetanus vaccines doses to Sri Lanka which led to a rise in the cases of whooping cough.
STC drug exports general manager B D Darwani said the important point is that this is a triple vaccine, and "if efficacy is poor, there should also have been an increase in the incidence of diphtheria and tetanus."
A committee set up by Sri Lanka's Health Ministry has found no evidence of a whooping cough epidemic, but the committee has said that it has not been possible to say whether the vaccine was faulty or not, and that to confirm quality it would have been necessary to test the vaccine at various points in the distribution chain. Reportedly, the vaccines were tested and cleared by the Sri Lankan health authorities.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze